Cytoxan
® (
cyclophosphamide) is a prescription chemotherapy medication that is used to treat different types of cancer. It is also approved to treat certain kidney problems in children. Specifically, the drug is approved to treat the following cancers:
Cytoxan is approved to treat "minimal change" nephrotic syndrome in children (a kidney disorder) when other treatments have failed.
Cytoxan is made by Bristol-Myers Squibb.
Cytoxan is part of a group of medications called alkylating agents.
The medication itself is not active against cancer, but it is metabolized by the liver into its active form. The active form causes "cross-linking" of DNA cells. When DNA is cross-linked, it can no longer function properly. Since DNA is essential for cells to grow and multiply, alkylating medications prevent cell growth and multiplication, and may cause cell death.
While Cytoxan can kill both healthy and cancerous cells, it has a greater effect on cells that are multiplying rapidly. Generally, cancer cells multiply more rapidly than healthy cells and are, therefore, more affected by the drug.
Cytoxan also suppresses the immune system, which is probably how it works to treat nephrotic syndrome.